Nitric Oxide SynthaseAnemia, RefractoryNitric Oxide Synthase Type IIRefractory Period, ElectrophysiologicalOxidesNitric Oxide Synthase Type IIINitric Oxide Synthase Type IAnemia, Refractory, with Excess of BlastsNitrogen OxidesZinc OxideTreatment OutcomeSalvage TherapyNG-Nitroarginine Methyl EsterNitritesRecurrenceArginineEnzyme InhibitorsDose-Response Relationship, Drugomega-N-MethylarginineNitratesDrug Administration ScheduleAntineoplastic Combined Chemotherapy ProtocolsAntineoplastic AgentsDrug Resistance, NeoplasmTime FactorsAmino Acid OxidoreductasesS-Nitroso-N-AcetylpenicillamineCyclic GMPNitroprussideInfusions, IntravenousRemission InductionAntibodies, Monoclonal, Murine-DerivedEndothelium, VascularThalidomidePenicillamineMagnesium OxideNitroso CompoundsAnticonvulsantsDrug ResistanceFerrosoferric OxideCytarabineTreatment FailureCells, CulturedBoronic AcidsEpilepsyVasodilationPyrazinesRefractory Period, PsychologicalRats, Sprague-DawleyAntibodies, MonoclonalEtoposideVasodilator AgentsMaximum Tolerated DoseMolsidomineFollow-Up StudiesDrug EvaluationAluminum OxideGuanylate CyclaseFerric CompoundsAnemia, SideroblasticMultiple MyelomaTransplantation, AutologousLymphoma, Non-HodgkinS-NitrosoglutathioneHodgkin DiseaseRats, WistarPain, IntractableDrug Therapy, CombinationArabinonucleosidesRetrospective StudiesCitrullineImmunosuppressive AgentsEpilepsies, PartialHeart Conduction SystemVidarabineNeoplasm Recurrence, LocalDogsDisease-Free SurvivalPiracetamLipopolysaccharidesS-NitrosothiolsCyclophosphamideNeoplasmsDexamethasoneSignal TransductionAnti-Arrhythmia AgentsCardiac Pacing, ArtificialMyelodysplastic SyndromesRNA, MessengerBlood PressureAtrioventricular NodeAscitesCombined Modality TherapyDeuterium OxideAdministration, OralHematopoietic Stem Cell TransplantationAnti-Inflammatory AgentsSurvival AnalysisBiopterinEnzyme Induction